Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway
EMBO Molecular Medicine,
Год журнала:
2024,
Номер
16(12), С. 3218 - 3246
Опубликована: Сен. 20, 2024
The
beneficial
effects
of
Neural
Precursor
Cell
(NPC)
transplantation
in
several
neurological
disorders
are
well
established
and
they
generally
mediated
by
the
secretion
immunomodulatory
neurotrophic
molecules.
We
therefore
investigated
whether
Rett
syndrome
(RTT),
that
represents
first
cause
severe
intellectual
disability
girls,
might
benefit
from
NPC-based
therapy.
Using
vitro
co-cultures,
we
demonstrate
that,
sensing
pathological
context,
NPC-secreted
factors
induce
recovery
morphological
synaptic
defects
typical
Mecp2
deficient
neurons.
In
vivo,
prove
intracerebral
NPCs
RTT
mice
significantly
ameliorates
functions.
To
uncover
molecular
mechanisms
underpinning
benefic
effects,
analyzed
transcriptional
profile
cerebellum
transplanted
animals,
disclosing
possible
involvement
Interferon
γ
(IFNγ)
pathway.
Accordingly,
report
capacity
IFNγ
to
rescue
defects,
as
motor
cognitive
alterations
models,
thereby
suggesting
this
pathway
a
potential
therapeutic
target
for
RTT.
Язык: Английский
BIOCHEMICAL AND MOLECULAR DETERMINANTS OF THE SUBCLINICAL INFLAMMATORY MECHANISMS IN RETT SYNDROME
Archives of Biochemistry and Biophysics,
Год журнала:
2024,
Номер
757, С. 110046 - 110046
Опубликована: Май 28, 2024
To
date,
Rett
syndrome
(RTT),
a
genetic
disorder
mainly
caused
by
mutations
in
the
X-linked
MECP2
gene,
is
increasingly
considered
broad-spectrum
pathology,
instead
of
just
neurodevelopmental
disease,
due
to
multitude
peripheral
co-morbidities
and
compromised
metabolic
pathways,
affecting
patients.
The
altered
molecular
processes
include
an
impaired
mitochondrial
function,
perturbed
redox
homeostasis,
chronic
subclinical
inflammation
improper
cholesterol
metabolism.
persistent
inflammatory
condition
was
first
defined
ten
years
ago,
as
previously
unrecognized
feature
RTT,
playing
role
pathology
progress
modulation
phenotypical
severity.
In
light
this,
present
work
aims
at
reviewing
current
knowledge
on
status
immune/inflammatory
functions
well
investigating
emerging
mechanisms
underlying
this
with
special
focus
latest
findings
about
inflammasome
system,
autoimmunity
responses
intestinal
micro-
mycobiota.
On
these
bases,
although
further
research
needed,
future
therapeutic
strategies
able
re-establish
adequate
response
could
represent
potential
approaches
for
RTT
Язык: Английский
A novel approach to metabolic profiling in case models of MECP2-related disorders
Metabolic Brain Disease,
Год журнала:
2025,
Номер
40(2)
Опубликована: Фев. 13, 2025
Abstract
Genetic
abnormalities
of
the
MECP2
gene
cause
several
conditions
grouped
under
umbrella
term
-related
disorders
and
characterized
by
a
variety
phenotypes.
We
applied
functional
approach
to
identify
metabolic
profiles
in
two
patients
with
Rett
syndrome
(RTT)
one
patient
duplication
(MRXSL).
Such
an
is
based
on
Phenotype
Mammalian
Microarray
(PM-M)
technology,
which
designed
assess
cellular
production
energy
presence
different
compounds
generating
distinct
environments.
The
findings
three
case
models
were
compared
versus
50
controls.
Although
small
number
samples
prevented
most
results
from
reaching
significant
p
-values
when
adjusted
Benjamini-Hochberg
correction,
some
interesting
trends
emerged.
Some
indicated
shared
conditions,
like
increased
sources
such
as
pectin,
adenosine,
pyruvic
acid,
or
decreased
response
certain
hormones.
Other
showed
opposite
for
disorders,
interleukin-1
beta
(IL-1
beta),
caused
RTT
group
but
MRXSL.
IL-1
also
offers
valuable
insights
into
pathogenic
mechanism
potential
therapeutic
approaches.
profiling
bears
remarkable
translational
since
it
may
be
helpful
investigate
molecular
underlying
phenotypical
this
spectrum
develop
biomarkers
identification
ideal
candidates
treatments
recently
approved
trofenatide,
targets
development
novel
Язык: Английский
Exploring the complexity of MECP2 function in Rett syndrome
Nature reviews. Neuroscience,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 13, 2025
Язык: Английский
Interpreting the rich dialogue between astrocytes and neurons: An overview in Rett syndrome
Brain Research Bulletin,
Год журнала:
2025,
Номер
227, С. 111386 - 111386
Опубликована: Май 15, 2025
Язык: Английский
GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(21), С. 11555 - 11555
Опубликована: Окт. 28, 2024
Rett
syndrome
(RTT)
is
a
severe
neurodevelopmental
disorder
primarily
caused
by
mutations
in
the
methyl-CpG
binding
protein
2
(MECP2)
gene.
Despite
advancements
research,
no
cure
exists
due
to
an
incomplete
understanding
of
molecular
effects
MeCP2
deficiency.
Previous
studies
have
identified
impaired
tropomyosin
receptor
kinase
(Trk)
neurotrophin
(NTP)
signaling
and
mitochondrial
redox
imbalances
as
key
drivers
pathology.
Moreover,
altered
glycosphingolipid
metabolism
has
been
reported
RTT.
GM1
ganglioside
known
regulator
nervous
system,
growing
evidence
indicates
its
importance
maintaining
neuronal
homeostasis
via
oligosaccharide
chain,
coded
GM1-OS.
GM1-OS
directly
interacts
with
Trk
receptors
on
cell
surface,
triggering
neurotrophic
neuroprotective
pathways
neurons.
In
this
study,
we
demonstrate
that
ameliorates
RTT
deficits
Mecp2-null
model.
restored
synaptogenesis
reduced
oxidative
stress
Mecp2-knock-out
(ko)
cortical
When
administered
vivo,
mitigated
RTT-like
symptoms.
Our
findings
indicate
were
mediated
activation
neuron’s
plasma
membrane.
Overall,
our
results
highlight
promising
candidate
for
treatment.
Язык: Английский
Molecular Mechanisms of Rett Syndrome: Emphasizing the Roles of Monoamine, Immunity, and Mitochondrial Dysfunction
Júlia Lopes Gonçalez,
Jenny Shen,
Wei Li
и другие.
Cells,
Год журнала:
2024,
Номер
13(24), С. 2077 - 2077
Опубликована: Дек. 17, 2024
Rett
syndrome
(RTT),
which
predominantly
affects
females,
arises
in
most
cases
from
mutations
the
Methyl-CpG-binding
Protein-2
(MECP2)
gene.
When
MeCP2
is
impaired,
it
disrupts
regulation
of
numerous
genes,
causing
production
dysfunctional
proteins
associated
with
various
multi-systemic
issues
RTT.
In
this
review,
we
explore
current
insights
into
molecular
signaling
related
to
monoamines,
immune
response,
and
mitochondrial
function,
their
implications
for
pathophysiology
Research
has
shown
that
monoamines—such
as
dopamine,
norepinephrine,
epinephrine,
serotonin,
histamine—exhibit
alterations
RTT,
contributing
a
range
neurological
symptoms.
Furthermore,
system
RTT
individuals
demonstrates
dysfunction
through
abnormal
activity
microglia,
macrophages,
lymphocytes,
non-immune
cells,
leading
atypical
release
inflammatory
mediators
disruptions
NF-κB
pathway.
Moreover,
mitochondria,
essential
energy
calcium
storage,
also
show
condition.
The
delicate
balance
producing
scavenging
reactive
oxygen
species—termed
redox
balance—is
disrupted
Targeting
these
pathways
presents
promising
avenue
developing
effective
therapies.
Язык: Английский